. Dose response curve for 17-AAG and 17-DMAG treatment on Burkitt Lymphoma. Dose response growth curve on Raji Burkitt Lymphoma cell line with (A) 0.5-6µM 17-AAG compared to Methanol (MeOH) control; and (B) 0.1-2µM 17-DMAG compared to untreated control. 
. Dose response curve for 17-AAG and 17-DMAG treatment on Burkitt Lymphoma. Dose response growth curve on Raji Burkitt Lymphoma cell line with (A) 0.5-6µM 17-AAG compared to Methanol (MeOH) control; and (B) 0.1-2µM 17-DMAG compared to untreated control. using propidium iodide (PI) staining upon three days treatment with 4µM 17-AAG. Cell cycle distribution (G1, S and G2/M) are displayed in percent. (F) RT-qPCR of CDKN2b and CDKN1a upon three day treatment of 4 µM 17-AAG or methanol control. RT-qPCR was normalized to RPL13a; Tubulin was used as a loading control for WB. Error bars represent mean ± SEM; n = 3; two-tailed Student's t-test: NS = not significant; * p < 0.05; ** p < 0.01; *** p < 0.001. 
